Sameer Saleem is a Cardiology physician. OpenAlex indexes 56 publications with 212 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2900 N Lake Shore Dr
Chicago, IL 606575640
Telephone
773-665-3022Provider last certified this registry record 18 Jan 2023.
Industry payments
39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20258 payments
- ABIOMEDProgram year202513 payments
- E.R. Squibb & Sons, L.L.C.Program year202513 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.5%Beta blocker22.3%Metoprolol Succinate50%Carvedilol25%Metoprolol Tartrate25%Part D≥75 patientsStatin10.1%Atorvastatin Calcium72%Rosuvastatin Calcium28%Part D≥61 patients+ 12 more classes in this area
Blood & clotting
25.4%Factor Xa inhibitor11.8%Eliquis87%Xarelto13%Part D≥64 patientsP2Y12 inhibitor11.3%Clopidogrel52%Brilinta43%Prasugrel Hcl6%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
3%SGLT2 inhibitor1.8%Farxiga59%Jardiance41%Part D<11 patientsPotassium supplement1.3%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ARRHYTHMIAS LEADING TO CARDIAC ARREST CAUSED BY CARDIAC COMPRESSION FROM SEVERE PECTUS EXCAVATUM
Journal of the American College of Cardiology
2025 - Relationship of Hemodynamic Improvement and Quality of Life Outcomes After Transcatheter Aortic Valve Replacement
Catheterization and Cardiovascular Interventions
2025 - Systematic review and meta-analysis comparing Manta device and Perclose device for closure of large bore arterial access
The Journal of Vascular Access
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”